Medical Journals

"Therapeutic Time Window" Duration Decreases with Increasing Severity of Cerebral Hypoxia-ischaemia Under Normothermia and Delayed Hypothermia in Newborn Piglets.

Authors:
  • Iwata Osuke
  • Iwata Sachiko
  • Thornton John S
  • De Vita Enrico
  • Bainbridge Alan
  • Herbert Linda
  • Scaravilli Francesco
  • Peebles Donald
  • Wyatt John S
  • Cady Ernest B
  • Robertson Nicola J

From: Centre for Perinatal Brain Research, Institute for Women’s Health, University College London, and Lysholm Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, London, UK. o.iwata@orbix.uk.net

Brain research

  • Publish Date: Jun 2007
  • ISSN: 0006-8993
  • Volume: 1154
  • Issue:
  • Pages: 173-80
  • Medium: Print
  • Language: English
  • Citation (JAMA): Iwata Osuke, Iwata Sachiko, Thornton John S, et al. "Therapeutic Time Window" Duration Decreases with Increasing Severity of Cerebral Hypoxia-ischaemia Under Normothermia and Delayed Hypothermia in Newborn Piglets.. Brain Res. Jun 2007;1154:173-80

Abstract

OBJECTIVE: For optimal neuroprotection following transient perinatal hypoxia-ischaemia (HI), therapy should start before overt secondary energy failure and its irreversible neurotoxic cascade. Hypothermia is a promising neuroprotective intervention that also prolongs the therapeutic time window (“latent-phase”; the period between re-establishment of apparently normal cerebral metabolism after HI, and the start of secondary energy failure). The influences of HI severity on latent-phase duration and regional neuroprotection are unclear. Under normothermia and delayed whole-body cooling to 35 and 33 degrees C we aimed to assess relationships between HI severity and: (i) latent-phase duration; (ii) secondary-energy-failure severity; and (iii) neuronal injury 48 h following HI. METHODS: Newborn piglets were randomized to: (i) HI-normothermia (n=12), (ii) HI-35 degrees C (n=7), and (iii) HI-33 degrees C (n=10). HI-35 degrees C and HI-33 degrees C piglets were cooled between 2 and 26 h after HI. Insult and secondary-energy-failure severity and latent-phase duration were evaluated using phosphorus magnetic resonance spectroscopy and compared with neuronal death in cortical-grey and deep-grey matter. RESULTS: More severe HI was associated with shorter latent-phase (p=0.002), worse secondary energy failure (p=0.023) and more cortical-grey-matter neuronal death (p=0.016). CONCLUSIONS: Latent-phase duration is inversely related to insult severity; latent-phase brevity may explain the apparently less effective neuroprotection following severe cerebral HI.

Mesh Headings (Keywords): Analysis of Variance, Animals, Animals, Newborn, Cell Death, Disease Models, Animal, Female, Hypothermia, Induced, Hypoxia-Ischemia, Brain, Magnetic Resonance Spectroscopy, Male, Nerve Degeneration, Random Allocation, Severity of Illness Index, Swine, Time Factors


Check for Full Text / PubMed Unique Identifier (PMID): 17475224


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.